2nd Scientific Advisory Board Meeting

A bit over one year after meeting with our Scientific Advisory Board (SAB) for the first time, our LBI:AD had their second meeting with the SAB last week on the 13th of May 2019. The SAB consists of five internationally renowned experts, which were again invited to review our institute’s research, to evaluate our progress […]

What about industry?

Thomas Dillinger, PhD student of our LBI’s Program Line Molecular Pathology, has spent two months with Boehringer Ingelheim in Vienna to gain insights into the research-driven pharmaceutical industry, to pick up on new laboratory techniques and to establish fruitful connections with new colleagues from various fields of expertise. His stay was funded thanks to a […]

Keio University

Japan – One Year Later

By Loan Tran, PhD student, PL Molecular Pathology, Egger group Internship (05.02.18-30.03.18) at Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Tokyo, Japan Founded in 1858, Keio is one of the most prestigious private universities in Japan. Exactly one year ago, I had the honor to join the laboratory of Assoc. Prof. Yoshimasa Saito and […]

Congratulations!

Congratulations to Dr. med. univ. Johannes Längle to the Researcher of the Month Award! Fitting to this month’s Colorectal Cancer Awareness Campaign, the award was bestowed by the Medical University of Vienna on occasion of his recent publication about colorectal liver metastases and the implication of DNA damage with their prognosis and treatment response. The […]

13th OGNMB Congress in January 2019

The 13th National OGNMB Congress took place from the 23rd to the 25th of January 2019 in Zell am See (Austria), a township in the state of Salzburg with 9852 citizens. Zell am See is loved as a destination thoughout the whole year, since it offers great possibilities for skiing and other wintersports as well […]

Markus Zeitlinger received several grants

Congratulations to Markus Zeitlinger, head of the Department of Clinical Pharmacology and key researcher of LBI:AD’s program line Clinical Applications. He received several grants for projects within the „AMR Accelerator Program“ of the Innovative Medicine Initiative (IMI). The Initiative supports studies targeting the investigation of multi-drug resistance to antibiotics. Read more >>here<<

Johannes Längle erhielt den Theodor-Billroth-Preis

(Wien, 08-01-2019) Der Theodor-Billroth-Preis der Wiener Ärztekammer ging heuer dreigeteilt mit Johannes Koren und Johannes Längle an zwei Forscher der MedUni Wien sowie an Maximilian Tscharre vom Landesklinikum Wiener Neustadt. Zum Theodor-Billroth-Preis der Ärztekammer für Wien Zur Förderung wissenschaftlicher Arbeiten stiftet die Ärztekammer für Wien den „Theodor-Billroth-Preis der Ärztekammer für Wien”. Der „Theodor-Billroth-Preis” wird alljährlich […]

LBG Health Science Meeting

LBG Meeting for Health Sciences 2018

The LBG Meeting for Health Sciences 2018 took place in Vienna on the 29th and 30th of November. The focus was on the translation of research results from theory into practice. Therefore, researchers were asked to submit abstracts for presentation on preclinical, clinical or implementation research with emphasis on Cardiovascular research, Haematology and cancer research, […]

Press conference “Movember”

To raise awareness for men’s health issues, the Ludwig Boltzmann Institute Applied Diagnostics hold together with representatives of the Medical University of Vienna a press conference at the Presseclub Concordia in Vienna. The aim was to inform about the current research and therapy status of prostate cancer but also to address the importance of medical […]

Header Weinherbst

Der LBG Weinherbst 2018

“Wir waren auf der Suche nach Druckpunkten bei der Diagnose, Behandlung und Rehabilitation von Unfallverletzungen. Diese haben wir bei einer Crowdsourcing-Kampagne, die über den Sommer gelaufen ist, herausgefunden”, erzählte LBG-Präsident Josef Pröll beim Weinherbst am 22. Oktober in Wien. “800.000 Menschen verunfallen jedes Jahr und werden in österreichischen Krankenhäusern behandelt. Dabei entsteht ein wertvoller Wissensschatz, […]